Phase II Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Cisplatin; Pemetrexed
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms MesoMab
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 07 Feb 2017 Status changed from recruiting to completed.
- 04 Dec 2014 Planned End Date changed from 1 Sep 2013 to 1 Sep 2015 as reported by ClinicalTrials.gov.